Arxada, a global leader in innovative solutions dedicated to protecting our world, has secured $100,000 in new investment capital from investors. This funding round provides additional financial resources for the company, which is renowned for its groundbreaking technologies, in-depth regulatory know-how, and advanced manufacturing capabilities. Arxada's core mission involves safeguarding nutrition, health, and infrastructure efficiently through chemistry and biotechnology that enhance sustainability.
Headquartered in Basel, Switzerland, Arxada operates across multiple end-markets, including Human Health & Nutrition, Home & Personal Care, Professional Hygiene, Paints & Coatings, and Wood Protection. The company’s broad portfolio of ingredients and services serves customers in over 100 countries, achieving sales of CHF 2 billion in 2024. With 3,200 associates across 24 production sites and 14 R&D centers, Arxada focuses on enhancing sustainability through its offerings.
The newly raised capital will be directed towards supporting Arxada's ongoing strategic initiatives and operational enhancements. While specific deployment details for this particular investment were not publicly disclosed, the company plans to utilize these funds to further its commitment to innovation, research and development, and market expansion across its diverse portfolio. This investment reinforces Arxada's dedication to developing advanced solutions that meet evolving global demands in its key sectors.
Arxada, held by Herens Midco S.à r.l, continues to emphasize its mission of delivering solutions that protect and enhance the world. This latest funding round is expected to contribute to the company's efforts in advancing its technological capabilities and strengthening its position as a leader in sustainable chemical and biotechnological solutions for its diverse customer base. The company remains focused on driving continued growth and delivering value across its global operations, supporting its long-term strategic vision.
.png&w=3840&q=75)
